Search Login Register

Epirubicin (Ellence) Summary

Description: An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.

Also Known As: Ellence; 4'-Epi-Adriamycin; 4'-Epi-DXR; 4'-Epi-Doxorubicin; EPI-cell Show All >>

Networked: 2778 relevant articles (340 outcomes, 1059 trials/studies) for this Drug

Key Diseases for which Epirubicin is Relevant

  1. Breast Neoplasms (Breast Cancer) : 132 outcomes 470 studies in 1062 results
  2. Neoplasms (Cancer) : 60 outcomes 154 studies in 584 results
  3. Urinary Bladder Neoplasms (Bladder Cancer) : 32 outcomes 53 studies in 150 results
  4. Hepatocellular Carcinoma (Hepatoma) : 28 outcomes 29 studies in 119 results
  5. Carcinoma (Carcinomatosis) : 21 outcomes 68 studies in 197 results
Show All >>

Drugs Related to Epirubicin

  1. Fluorouracil (Carac)
  2. Cisplatin (Platino)
  3. Cyclophosphamide (Cytoxan)
  4. docetaxel (Taxotere)
  5. Paclitaxel (Taxol)
  6. Doxorubicin (Adriamycin)
  7. capecitabine (Xeloda)
  8. Mitomycin (Mitomycin-C)
  9. vinorelbine (Navelbine)
  10. Methotrexate (Mexate)
Show All >>

Therapies Related to Epirubicin

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Adjuvant Chemotherapy
  4. Intravesical Administration
  5. Radiotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.